Jefferies last had Merck as a $54 target, back in May of 2013. But back then it had Merck as a “buy” rating.
. . . .Jefferies Group increased their price objective on shares of Merck & Co from $50.00 to $54.00 in a note issued to investors on Thursday, American Banking & Market News reports. Jefferies Group’s price objective points to a potential upside of 8.46% from the company’s current price. . . .
Yawn. I like the Jefferies analysts, but like most, they see only incremental moves ahead for Whitehouse Station. So, they move the price target up (and down) only marginally, it seems. So it goes.